EUCTR2008-005325-10-NL进行中（未招募）不适用
The effect of exenatide compared to insulin glargine on cardiac function and metabolism in type 2 diabetic patients with congestive heart failure (NYHA II): a randomized-controlled trial
VU University Medical Center0 个研究点目标入组 42 人开始时间: 2008年10月14日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •type 2 diabetic patients
- •age 40-70 years
- •metformin therapy
- •HbA1 6.5 - 10%
- •Congestive heart failure (NYHA II)
- •Ejection fraction <40 %
- •Stable standard therapy for their cardiac condition
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •type 1 diabetes mellitus
- •serious renal or liver impairment
- •malignant disease
- •cardiovascular event < 3 months prior to inclusion
- •contraindications for CMR
- •Use of insulin, thiazolidinediones, incretin-based therapies (within 4 months of screening), glucocorticoids, NSAIDs or centrally acting drugs
研究者
相似试验
已完成
4 期
The effect of exenatide compared to insulin glargine on cardiac function and metabolism in type 2 diabetic patients with congestive heart failure: a randomized-controlled trialDiabetic cardiomyopathyNL-OMON35173Vrije Universiteit Medisch Centrum62
进行中（未招募）
不适用
Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate TherapyMedDRA version: 6.1Level: 5Classification code 10012607Type 2 Diabetes MellitusEUCTR2004-000349-40-ITELI LILLY
已完成
4 期
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesDiabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseNCT02303730Fudan University76
已完成
4 期
A Comparison of Exenatide and Insulin GlargineType 2 DiabetesNCT02325960The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School44
已完成
4 期
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureType 2 Diabetes MellitusCongestive Heart FailureNCT00766857Amsterdam UMC, location VUmc27